IGF-1 LR3 Dosage Guide

Complete guide to IGF-1 LR3 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Research protocols typically use 20-100mcg daily, often divided into multiple injections or administered bilaterally to target muscles.

Administration Method

Intramuscular injection (site-specific growth) or subcutaneous for systemic effects. Often cycled 4-6 weeks on, equal time off.

Side Effects to Monitor

Hypoglycemia, joint pain, water retention, potential jaw/hand growth with extended use, and injection site reactions.

Safety Considerations & Risks

May promote growth of existing tumors. Can cause significant hypoglycemia. Long-term effects on insulin sensitivity concerning.